Skystar Bio-Pharma (SKBI) Balance Sheet

Click line-items for a historical chart and %

Cash
Accounts receivable, net of allowance for doubtful accounts of $345,736 (Unaudited) and $339,031 as of June 30, 2011 and December 31, 2010, respectively	35.35M
Inventories	23.11M
Deposits and prepaid expenses	1.71M
Loans receivable
Other receivables
Total current assets	120.86M
PLANT AND EQUIPMENT, NET
CONSTRUCTION-IN-PROGRESS	10.74M
Long-term prepayments	2.13M
Long-term prepayments for acquisitions	3.25M
Intangible assets, net	5.01M
Total other assets	10.39M
Total assets	171.61M
Accounts payable	9.4M
Other payable and accrued expenses
Short-term loans	19.18M
Deposits from customers	1.66M
Taxes payable	7.97M
Shares to be issued to related parties
Due to related parties	2.96M
Total current liabilities	48.31M
Deferred government grant	796.25K
Warrant liability	0
Total other liabilities	796.25K
Total liabilities	49.1M
COMMITMENTS AND CONTINGENCIES	0
Preferred stock, $0.001 par value, 50,000,000 shares authorized, No Series "A" shares authorized, 48,000,000 Series "B" shares authorized, No Series "B" shares issued and outstanding	1
Common stock, $0.001 par value, 40,000,000 shares authorized, 7,161,919 shares issued and outstanding as of June 30, 2011 (Unaudited) and December 31, 2010	8.5K
Paid-in capital	41.88M
Statutory reserves	5.95M
Retained earnings	63.69M
Accumulated other comprehensive income	10.97M
Total shareholders' equity	122.5M
Total liabilities and shareholders' equity	171.61M

Entities mentioned with SKBI

View All Entities